<p>Telix Pharmaceuticals Limited announced that Ms. Tiffany Olson has resigned as Non-Executive Director and Board Chair, effective 3 February 2026. Dr. Mark Nelson, a long-standing independent Non-Executive Director, has been appointed as Interim Chair. The Board is in advanced stages of appointing new Non-Executive Directors and a new Independent Chair. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002007191-26-000006), on February 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

Telix Pharmaceuticals Appoints Dr. Mark Nelson as Interim Chair After Tiffany Olson Resignation